Ana Miar
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- interferon and immune responses
Papers in
-
- Cancer, Hypoxia, and Metabolism 2
-
- Ion channel regulation and function 2
- CRISPR and Genetic Engineering 1
- RNA modifications and cancer 1
- Co-authors
- Adrian L. Harris (6 shared papers)David Hevia (1 shared paper)Rosa María Sainz (1 shared paper)Juan Carlos Mayo (1 shared paper)Aurora Astudillo (1 shared paper)Julio Velasco (1 shared paper)Annamaria Biroccio (1 shared paper)Emilia Puig Lombardi (1 shared paper)
- Journals
- Free Radical Biology and Medicine (1 paper)Journal of Molecular Neuroscience (1 paper)Revista Española de Cardiología (English Edition) (1 paper)PLoS Computational Biology (1 paper)Nature Communications (1 paper)
- Partner nations
- SpainUnited KingdomItaly
In The Last Decade
Ana Miar
12 papers receiving 387 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 85
- Immunology 100
- Oncology 100
- Molecular Biology 228
- Reproductive Medicine 11
Countries citing papers authored by Ana Miar
This map shows the geographic impact of Ana Miar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Miar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Miar more than expected).
Fields of papers citing papers by Ana Miar
This network shows the impact of papers produced by Ana Miar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Miar. The network helps show where Ana Miar may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Miar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 159 | |
| 2 | 2015 | 113 | |
| 3 | 2010 | 41 | |
| 4 | 2021 | 21 | |
| 5 | 2011 | 15 | |
| 6 | 2010 | 10 | |
| 7 | 2010 | 8 | |
| 8 | 2021 | 8 | |
| 9 | 2024 | 8 | |
| 10 | 2024 | 4 | |
| 11 | 2011 | 3 | |
| 12 | Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer | 2017 | 2 |
About Ana Miar
Ana Miar is a scholar working on Cancer Research, Molecular Biology, Cardiology and Cardiovascular Medicine, Modeling and Simulation and Physiology, having authored 12 papers that have together received 392 indexed citations. Recurring topics across this work include ECG Monitoring and Analysis (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Ion channel regulation and function (2 papers), Alzheimer's disease research and treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), CRISPR and Genetic Engineering (1 paper), RNA modifications and cancer (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Cancer Research (85 citations), Immunology (100 citations), Oncology (100 citations), Molecular Biology (228 citations) and Reproductive Medicine (11 citations). Ana Miar has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include Adrian L. Harris, David Hevia, Rosa María Sainz, Juan Carlos Mayo, Aurora Astudillo, Julio Velasco, Annamaria Biroccio, Emilia Puig Lombardi, Madalena Tarsounas and Helen E. Lockstone. Their work appears in journals such as Free Radical Biology and Medicine, Journal of Molecular Neuroscience, Revista Española de Cardiología (English Edition), PLoS Computational Biology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.